Two negative trials of lithium in ALS


REPORT FROM THE AAN, APRIL 10-17, 2010 – In 2008, Italian researchers reported that lithium 300-450 mg/day delayed disease progression in amyotrophic lateral sclerosis (Fornai et al. PNAS 2008; 105: 2052-2057; free full text at

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page